Navigation Links
Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
Date:8/11/2011

DEXTA® are trademarks or registered trademarks of Avanir Pharmaceuticals, Inc. in the United States and other countries.  All other trademarks and service marks are the property of their respective owners

©2011 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Forward Looking Statements

Except for the historical information contained herein, the matters set forth in this press release, including statements regarding Avanir's plans, potential opportunities, financial or other expectations, projections, goals objectives, milestones, strategies, market growth, timelines, legal matters, product pipeline, clinical studies, product development and the potential benefits of its commercialized products and products under development are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties associated with litigation, including, but not limited to Avanir's ability to protect its patents and other intellectual property, and other risks detailed from time to time in the Company's most recent Annual Report on Form 10-K and other documents subsequently filed with or furnished to the Securities and Exchange Commission. These forward-looking statements are based on current information that may change and you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and the Company undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.


'/>"/>
SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
4. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
5. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
7. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
9. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
10. Avanir Pharmaceuticals to Present at Three Conferences in March
11. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)...   Intarcia Therapeutics, Inc. today announced the ... an equity conversion option at a $5.5 billion Company ... the initiation of additional head-to-head comparative and switch studies ... 2 diabetes therapies. In addition, proceeds from the financing ... launch ITCA 650 in the United States ...
(Date:4/27/2015)... 2015 Array BioPharma Inc. (Nasdaq: ... third quarter of fiscal 2015 and hold ... on Monday, May 4, 2015.  Ron Squarer, ... May 4, 2015Time:9:00 a.m. Eastern TimeToll-Free:(844) 464-3927Toll:(765) ... Conference Call Slides:  http://edge.media-server.com/m/p/8tsxszuw/lan/en ...
(Date:4/27/2015)... THE WOODLANDS, Texas , April 27, 2015 /PRNewswire/ ... a biopharmaceutical company focused on developing breakthrough treatments for ... results on Wednesday, April 29, 2015 after the financial ... and webcast to discuss clinical development progress and financial ... Eastern Time on April 29, 2015. The ...
Breaking Medicine Technology:Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 2Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 3Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015 2
(Date:4/28/2015)... Dead or damaged trees can quickly turn into ... cases, tree removal by a skilled team is recommended as ... , In their latest article , Precision Tree ... property owners today. Each method requires skill and expertise that ... , The article states that, “Tree removal is not “one ...
(Date:4/28/2015)... Once considered an unproven alternative to HID lighting, the ... storm with perfectly tailored light spectrums in an ideal, low ... than half of every SuperCloset and SuperRoom sold are now ... is gone and LED Grow Lights are here to stay. ... their first hand experience using the new LED Grow lights ...
(Date:4/28/2015)... The Awareness Counselor team has introduced a new ... According to Awareness Counselor, there are ramifications of judging. Judging ... to an individual who self-judges. This new concept is now ... or one one one talk. , The premise of this ... that every being on earth is here for a purpose ...
(Date:4/28/2015)... April 28, 2015 LifeAID® ... and convenient nutrition for every lifestyle, announced ... through United Natural Foods Inc (UNFI), the ... and specialty foods including nutritional supplements. FitAID®, ... to thousands of retailers and consumers through ...
(Date:4/27/2015)... 27, 2015 Churchview Supportive Living, a ... Day Brunch and Fashion Show from 10:30 a.m. to ... located at 2626 W. 63rd St. in Chicago, serves ... some help to maintain their independence. , “Mothers, grandmothers, ... a Mother’s Day Brunch,” said Director of Marketing Elizabeth ...
Breaking Medicine News(10 mins):Health News:Tree Removal Methods and Services Discussed in Recent Article by Precision Tree Services 2Health News:SuperCloset Reports Surge in KIND LED Grow Light Sales, Saving Indoor Growing Enthusiasts up to 40% on their Power Usage. 2Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 2Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 3Health News:LifeAID Beverage Co. Announces Expanded Distribution Roll Out Through UNFI -- United Natural Foods Inc. 2Health News:LifeAID Beverage Co. Announces Expanded Distribution Roll Out Through UNFI -- United Natural Foods Inc. 3Health News:Churchview Supportive Living Community in Chicago to Host Mother's Day Brunch 2
... studies to establish an effective treatment for Duchenne Muscular Dystrophy ... myostatin - a protein that inhibits muscle growth - might ... Wagner of John Hopkins University showed in a new study, ... DMD is increased by the loss of the myostatin gene. ...
... Every one of us knows and understands that happy relationships ... know that the continuous //tension of a distressed intimate relationship ... According to a new study by researchers in Canada, when ... heart health. ,The study which was conducted over a ...
... have boosted confidence in a method used to repair cardiac ... stem cells derived from bone marrow which is much less ... heart attack and had undergone conventional bypass therapy. ,Doctors ... heart attack were injected with bone marrow stem cells into ...
... one of the most common reason which results in ... common and potentially dangerous bug which causes this ... bacterium is found naturally in the environment and survives ... for long periods. This bacterium which is not harmful ...
... age people are now increasingly taking to gardening as a ... of beautiful gardens. Though gardening has been proven to have ... gardeners who start with little or no idea of how ... up having severe back pain. ,A recent study of ...
... fall at least once in our life. But how many of ... not even a few of us. But researchers at the Locomotion ... a fall// will help prevent them better. The researchers, who claim ... institutionalized or even die due to a fall, have taken up ...
Cached Medicine News:Health News:Myostatin gene could hold the key to treatment for DMD 2Health News:Unhappy relationships could result in more than just heart breaks! 2Health News:Machines take over the battle against hospital bugs 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: